SimoneKrebsMD

Nuclear Medicine • New York, NY

Assistant Attending

Join to view full profile

Dr. Krebs is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Krebs' full profile

Already have an account?

Office
303 E 60th St
Apt 32F
New York, NY 10022
Phone+1 832-640-8553

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Nuclear Medicine, 2016 - 2018
Memorial Sloan Kettering Cancer CenterResidency, Nuclear Medicine, 2014 - 2016
Albert Ludwigs University Faculty of MedicineClass of 2006

Certifications & Licensure

TX State Medical License 2024 - 2026
NJ State Medical License 2021 - 2025
NY State Medical License 2017 - 2025
American Board of Nuclear Medicine Nuclear Medicine

Clinical Trials

In-Human CXCR4 Imaging of Blood Cancers Using [68Ga]-Pentixafor-PET Start of enrollment: 2021 Oct 01
Recruiting
Early Phase 1
Roles: Contact, Principal Investigator
A Study of 68Ga-PSMA-11 PET Scans in People With Brain Tumors Start of enrollment: 2024 Jan 05
Recruiting
Early Phase 1
Roles: Contact, Principal Investigator

Publications & Presentations

PubMed

275 citations
Combinational Targeting Offsets Antigen Escape and Enhances Effector Functions of Adoptively Transferred T Cells in Glioblastoma
Meenakshi Hegde, Amanda Corder, Kevin Chow, Malini Mukherjee, Aidin Ashoori
Molecular Therapy. 2013-11-01
7 citations
CAR Chase: Where Do Engineered Cells Go in Humans?
Simone Krebs, Megan M. Dacek, Lukas M. Carter, David A. Scheinberg, Steven M. Larson
Frontiers in Oncology. 2020-09-11
16 citations
Genetically modified T cells to target glioblastoma.
Simone Krebs, Tania Rodriguez-Cruz, Christopher DeRenzo, Stephen Gottschalk
Frontiers in Oncology. 2013-12-31

Journal Articles

Biodistribution and Radiation Dose Estimates for 68Ga-DOTA-JR11 in Patients with Metastatic Neuroendocrine Tumors
Simone Krebs, Lisa Bodei, Diane Reidy, Bradley J Beattie, Wolfgang A Weber, European Journal of Nuclear Medicine and Molecular Imaging

Press Mentions

Novel PET, SPECT Techniques Help Track, Modify T Cells for ImmunotherapyJune 22nd, 2018